Pharmacokinetics of Equol, a Soy Isoflavone Metabolite, Changes with the Form of Equol (Dietary versus Intestinal Production) in Ovariectomized Rats

[Image: see text] Recent findings indicate that soy isoflavones and their metabolites may play a role in mitigating postmenopausal bone loss. Equol, a metabolite of the soy isoflavone daidzein produced by intestinal bacteria, has shown some potential, but only 30–50% of the U.S. population is capabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Legette, LeeCole L., Prasain, Jeevan, King, Jennifer, Arabshahi, Ali, Barnes, Stephen, Weaver, Connie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983397/
https://www.ncbi.nlm.nih.gov/pubmed/24446705
http://dx.doi.org/10.1021/jf400097m

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983397/
https://www.ncbi.nlm.nih.gov/pubmed/24446705
http://dx.doi.org/10.1021/jf400097m

Ejemplares similares